HIGHFDA DRUG

Chlorpromazine Hydrochloride Tablets Recalled Nationwide for Foreign Substance in Packaging Lot 1022

A high-severity recall covers chlorpromazine hydrochloride tablets distributed nationwide by American Health Packaging. A foreign substance linked to a polyester coil packaging component was detected at the manufacturing site. No tablets were contaminated. Stop using the product and contact the distributor for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 27, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 27, 2025
Hazard Level
HIGH
Brands
CHLORPROMAZINE HYDROCHLORIDE, American Health Packaging
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CHLORPROMAZINE HYDROCHLORIDE, American Health Packaging
Product type
Chlorpromazine Hydrochloride Tablets
Model numbers
Lot: 1022159, Lot: 1023299, Lot: 1024057
UPC codes
60687-419, 60687-430, 60687-441, 60687-452, 60687-463, 60687-419-11, 60687-419-01, 60687-430-11 +7 more
Sizes
50 mg
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 27, 2025

  2. Reported by FDA DRUG

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat psychotic disorders. It is typically prescribed by healthcare providers. The packaging involves blister packs and carton packaging.

Why This Is Dangerous

A foreign substance associated with an auxiliary polyester coil packaging component was detected at the manufacturing site. No micro-organism was found on tablets.

Industry Context

This recall appears not to be part of a broader industry pattern.

Real-World Impact

High severity due to potential packaging contamination risk. Immediate cessation of use advised.

Practical Guidance

How to identify if yours is affected

  1. Check carton label for NDC 60687-441-01 and individual-dose NDC 60687-441-11
  2. Verify packaging material for polyester coil components

Where to find product info

FDA enforcement report D-0648-2025 and recall notices

What timeline to expect

Refunds/replacements will be processed after recall communications, typically weeks

If the manufacturer is unresponsive

  • File a complaint with FDA
  • Contact pharmacist or healthcare provider for guidance

How to prevent similar issues

  • Verify packaging integrity on all medications
  • Purchase from reputable pharmacies
  • Keep lot information for future recalls

Documentation advice

Keep all recall letters, packaging, and prescription records

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Chlorpromazine Hydrochloride Tablets, USP 50 mg. Pack: 100 tablets per blisterpack, 10x10 blisters. Carton: 50 tablets in carton, NDC 60687-441-01, individual-dose NDC 60687-441-11. Distributor: Amerisource Health Services LLC doing business as American Health Packaging, Columbus, Ohio 43217. Quantity: 1,062 cartons. Distribution: Nationwide in the USA. Status: Active recall as of 2025-09-24.

Reported Incidents

No tablets were contaminated with micro-organisms. The notice indicates a foreign substance risk tied to packaging materials.

Key Facts

  • Distributor: American Health Packaging
  • Quantity recalled: 1,062 cartons
  • Status: Active recall as of 2025-09-24

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Lot: 1022159
Lot: 1023299
Lot: 1024057
UPC Codes
60687-419
60687-430
60687-441
+12 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

KVK-Tech Inc. Recalls Oxycodone Hydrochloride Tablets Over Seal Defects

KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.

OXYCODONE HYDROCHLORIDE
Defective container:
Read more